Breaking News Instant updates and real-time market news.

TTWO

Take-Two

$99.96

-3.46 (-3.35%)

07:55
05/14/19
05/14
07:55
05/14/19
07:55

Take-Two price target raised to $126 from $119 at Wedbush

Wedbush analyst Michael Pachter raised his price target for Take-Two to $126 from $119 following Q4 results that were above guidance and largely in-line with expectations. The analyst reiterates an Outperform rating on the shares as they continue to present a "compelling value."

  • 16

    May

  • 17

    May

  • 29

    May

  • 06

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 12

    Jun

  • 13

    Nov

TTWO Take-Two
$99.96

-3.46 (-3.35%)

05/01/19
BTIG
05/01/19
NO CHANGE
BTIG
Twitch viewership of Apex Legends has fallen dramatically, says BTIG
After reaching 50M users within a month, Twitch viewership for Electronic Arts' (EA) Apex Legends has fallen off dramatically, BTIG analyst Brandon Ross told investors yesterday in a blog post. The analyst, who notes he hasn't received a player number from EA's Respawn studio since early March, believes the Twitch metrics are very relevant about the state of in-game engagement. He thinks Apex Legends' engagement has suffered since Respawn has not provided enough content and has introduced content too slowly. Further, there have also been numerous technical problems, adds Ross. The challenges of Respawn to capitalize on the game's fast start show why free-to-play is unlikely to become a major threat to the traditional triple-A video game model, says the analyst. In addition, Ross' survey work indicates Activision Blizzard's Call of Duty was likely impacted the most by Apex Legends.
05/14/19
PIPR
05/14/19
NO CHANGE
Target $114
PIPR
Overweight
Take-Two price target lowered to $114 from $119 at Piper Jaffray
Piper Jaffray analyst Michael Olson lowered his price target for Take-Two Interactive to $114 from $119 saying the company last night reported "mixed" March quarter results, with revenue below and earnings above consensus. As expected and typical, Take-Two's initial fiscal 2020 earnings guidance is well below the Street, Olson tells investors in a research note. He believes NBA 2K19 had a strong performance in the quarter, generating a 79% increase in recurrent spending for the quarter. Olson keeps an Overweight rating on Take-Two shares.
05/14/19
STFL
05/14/19
NO CHANGE
Target $118
STFL
Buy
Take-Two lower than expected guidance probably conservative, says Stifel
Stifel analyst Drew Crum noted that Take-Two reported mixed Q4 results, stating that his sense is that the net bookings shortfall was likely due to Red Dead Redemption 2. The company's FY20 guidance for non-GAAP EPS of $3.75-$4.00 is probably conservative, said the analyst, who added that he is in the process of updating his model and he is "likely" to trim his estimates following the report and guidance. Crum currently has a Buy rating and $118 price target on Take-Two shares.
05/14/19
KEYB
05/14/19
NO CHANGE
Target $133
KEYB
Overweight
Take-Two price target lowered to $133 from $152 at KeyBanc
KeyBanc analyst Evan Wingren lowered his price target for Take-Two to $133 from $152 following slightly below expectations quarterly results. Nonetheless, the analyst remains positive on the stock as he feels like guidance embeds bearish scenarios for 2020, which provides him confidence on upside throughout 2020 with continued content execution. He reiterates an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

BIIB

Biogen

$230.70

1.49 (0.65%)

16:24
05/20/19
05/20
16:24
05/20/19
16:24
Initiation
Biogen initiated  »

Biogen initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

SWI

SolarWinds

$19.16

0.04 (0.21%)

16:23
05/20/19
05/20
16:23
05/20/19
16:23
Syndicate
SolarWinds files to sell 17.25M shares of common stock »

JPMorgan, Goldman Sachs,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 23

    May

AMGN

Amgen

$168.36

-1.5 (-0.88%)

16:21
05/20/19
05/20
16:21
05/20/19
16:21
Initiation
Amgen initiated  »

Amgen initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 31

    May

GM

General Motors

$36.98

-0.02 (-0.05%)

16:21
05/20/19
05/20
16:21
05/20/19
16:21
Periodicals
GM plans wind-down of Maven car-sharing service in some cities, WSJ says »

According to the Wall…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 04

    Jun

  • 05

    Jun

  • 01

    Aug

DBVT

DBV Technologies

$8.98

-0.21 (-2.29%)

, AIMT

Aimmune

$19.68

-0.41 (-2.04%)

16:20
05/20/19
05/20
16:20
05/20/19
16:20
Initiation
DBV Technologies, Aimmune initiated  »

Aimmune assumed with an…

DBVT

DBV Technologies

$8.98

-0.21 (-2.29%)

AIMT

Aimmune

$19.68

-0.41 (-2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 13

    Sep

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
05/20/19
05/20
16:20
05/20/19
16:20
Options
Closing CBOE SPX and VIX Index summary for May 20th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVNA

Carvana

$67.17

-0.935 (-1.37%)

16:19
05/20/19
05/20
16:19
05/20/19
16:19
Syndicate
Carvana files to sell 3.5M shares of Class A common stock »

Wells Fargo Securities,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

INCY

Incyte

$76.83

-0.41 (-0.53%)

16:19
05/20/19
05/20
16:19
05/20/19
16:19
Initiation
Incyte initiated  »

Incyte initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 24

    May

  • 31

    May

  • 05

    Jun

  • 13

    Jun

GOOG

Alphabet

$1,138.33

-23.56 (-2.03%)

, GOOGL

Alphabet Class A

$1,145.28

-23 (-1.97%)

16:19
05/20/19
05/20
16:19
05/20/19
16:19
On The Fly
Fly Intel: Wall Street's top stories for Monday »

Stocks have started the…

GOOG

Alphabet

$1,138.33

-23.56 (-2.03%)

GOOGL

Alphabet Class A

$1,145.28

-23 (-1.97%)

INTC

Intel

$43.58

-1.3 (-2.90%)

QCOM

Qualcomm

$76.61

-4.91 (-6.02%)

XLNX

Xilinx

$101.05

-3.71 (-3.54%)

AVGO

Broadcom

$272.59

-17.27 (-5.96%)

S

Sprint

$7.34

1.165 (18.87%)

TMUS

T-Mobile

$78.32

2.93 (3.89%)

F

Ford

$10.28

-0.01 (-0.10%)

FB

Facebook

$182.71

-2.56 (-1.38%)

QGEN

Qiagen

$38.05

0.96 (2.59%)

MDCO

The Medicines Co.

$34.25

1.24 (3.76%)

DISH

Dish

$33.24

-2.095 (-5.93%)

SATS

EchoStar

$41.97

1.55 (3.83%)

PDD

Pinduoduo

$20.78

-1.91 (-8.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 20

    May

  • 22

    May

  • 24

    May

  • 30

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 13

    Jun

  • 13

    Jun

  • 19

    Jun

  • 19

    Jun

  • 20

    Jun

  • 24

    Jul

  • 25

    Jul

  • 31

    Jul

  • 06

    Aug

  • 23

    Oct

  • 27

    Oct

GH

Guardant Health

$78.29

2.13 (2.80%)

16:18
05/20/19
05/20
16:18
05/20/19
16:18
Syndicate
Guardant Health files to sell 4.5M shares of common stock »

JPMorgan and BofA/Merrill…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 05

    Jun

  • 12

    Jun

  • 18

    Jun

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
05/20/19
05/20
16:17
05/20/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSM

Insmed

$28.08

-1.08 (-3.70%)

16:16
05/20/19
05/20
16:16
05/20/19
16:16
Syndicate
Insmed files to sell $250M of common stock »

Morgan Stanley & Co.,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
05/20/19
05/20
16:16
05/20/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEO

NeoGenomics

$23.19

0.22 (0.96%)

16:15
05/20/19
05/20
16:15
05/20/19
16:15
Syndicate
Breaking Syndicate news story on NeoGenomics »

NeoGenomics files $150M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 05

    Jun

  • 06

    Jun

  • 13

    Nov

BKNG

Booking Holdings

$1,751.62

-35.11 (-1.97%)

16:15
05/20/19
05/20
16:15
05/20/19
16:15
Initiation
Booking Holdings initiated  »

Booking Holdings assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

TRIP

TripAdvisor

$45.01

0.01 (0.02%)

16:13
05/20/19
05/20
16:13
05/20/19
16:13
Upgrade
TripAdvisor rating change  »

TripAdvisor upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 22

    May

  • 11

    Jun

EXPE

Expedia

$116.48

0.22 (0.19%)

16:13
05/20/19
05/20
16:13
05/20/19
16:13
Initiation
Expedia initiated  »

Expedia assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

MGM

MGM Resorts

$25.34

-0.54 (-2.09%)

16:11
05/20/19
05/20
16:11
05/20/19
16:11
Conference/Events
MGM Resorts participates in a conference call with UBS »

Leisure, Gaming &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 29

    May

KR

Kroger

$24.06

-0.165 (-0.68%)

16:10
05/20/19
05/20
16:10
05/20/19
16:10
Upgrade
Kroger rating change  »

Kroger upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

CLVS

Clovis

$16.35

-0.68 (-3.99%)

16:08
05/20/19
05/20
16:08
05/20/19
16:08
Hot Stocks
Clovis says Rubraca increased symptom-free period in ovarian cancer patients »

Clovis Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 06

    Jun

VRSK

Verisk Analytics

$141.45

-0.56 (-0.39%)

16:07
05/20/19
05/20
16:07
05/20/19
16:07
Conference/Events
Verisk Analytics management to meet with Cantor Fitzgerald »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

  • 05

    Jun

MRVL

Marvell

$21.73

-0.885 (-3.91%)

16:06
05/20/19
05/20
16:06
05/20/19
16:06
Hot Stocks
Marvell to acquire Avera Semiconductor for $650M in cash »

Marvell announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

VNE

Veoneer

$18.84

-0.03 (-0.16%)

16:06
05/20/19
05/20
16:06
05/20/19
16:06
Syndicate
Breaking Syndicate news story on Veoneer »

Veoneer files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

OCUL

Ocular Therapeutix

$3.35

-0.11 (-3.18%)

16:06
05/20/19
05/20
16:06
05/20/19
16:06
Hot Stocks
Ocular Therapeutix says OTX-TP failed to meet primary endpoint in Phase 3 trial »

Ocular Therapeutix…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

  • 10

    Nov

CBAY

CymaBay

$12.37

-0.24 (-1.90%)

16:05
05/20/19
05/20
16:05
05/20/19
16:05
Hot Stocks
CymaBay announces results related to seladelpar clinical development program »

CymaBay Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.